遮天辰东小说,古风名字,已完本玄幻小说排行榜

Microdiag Biomedical Technology Co., Ltd.

Microdiag Biomedical Technology Co., Ltd. was founded in 2008.9.9, located in the national nano high-tech industrialization base - Suzhou Nano City. It is a company focusing on cancer, Alzheimer's, acute infectious diseases and other major diseases. Monitoring is the entry point, focusing on innovative national high-tech enterprises that combine new markers/key technology raw materials/automatic instruments.

2008

Founded in

Certificate

400

Talents

Team and R&D Capability

The company has a team of nearly 400 professional and technical personnel with reasonable discipline structure, mastering international leading technology and innovative spirit, of which more than 30% have master's or doctoral degrees. There are 8 scientific and technological projects at the provincial, provincial and municipal levels, and the cumulative R&D investment exceeds 100 million yuan. It has more than 80 patents, including 8 international invention patents, and has built the "Postdoctoral Research Workstation" established by the Ministry of Human Resources and Social Security, the "Primede Precision Medicine Key Laboratory of Soochow University", and Jiangsu Cancer Hospital and Nanjing Medical University. Jointly established scientific research and academic institutions such as "Jiangsu Provincial Key Laboratory of Malignant Tumor Molecular Biology and Translational Medicine" and "Jiangsu Provincial Tumor Molecular Detection Translational Medicine Service Center".

Team style

Subsidiary and equipment scale

At present, there are 3 R&D and production companies, 3 medical testing laboratories, and 3 marketing companies for Zhenbi. The headquarters has a standardized molecular medicine laboratory of 2500 square meters, a class III in vitro diagnostic kit production workshop of 1500 square meters and a class II medical device production workshop of 3000 square meters. In April 2010, it obtained the production of class III in vitro diagnostic reagents and class II medical devices. License. Shanghai Liangrun Biomedical Technology Co., Ltd. has an 800-square-meter scientific research laboratory, a 2,000-square-meter GMP standard workshop, and has obtained the EU ISO13485 certification. It has developed a number of pioneering products and has an annual production capacity of 50 million reagents. Anhui Weizhen Bioengineering Technology Co., Ltd. is mainly engaged in the research and development of diagnostic instruments and supporting consumables. At present, it has successfully developed the world's first fully automatic methylation pretreatment equipment NEW-24, which is about to be independently developed for clinical trials. Particle chemiluminescence POCT equipment, nucleic acid rapid detection products, etc.

Technology-driven product-focused

Over the past 12 years, Weizhen Bio has always adhered to the strategy of "technology-driven, product-focused". At present, it has formed gastrointestinal cancer (CST4), tumor pan-cancer species (DR70), intestinal cancer (Septin9), prostate cancer (urine PCA3), Early detection products for major diseases such as bladder cancer (urine Vi/Tm), AD (plasma exosomal Aβ, p-Tau), sepsis diagnosis and monitoring, and self-testing of new coronavirus nucleic acid. In 12 years, "trying hard and trying hard, and continuing to attack the underlying technology of IVD", completed the preparation process and technological breakthrough of key IVD raw materials or consumables that are "stuck" in many industries, and continued to ensure the launch of efficient and exclusive new products in the next 10 years. The exclusive high-barrier products have formed the unique market competitiveness of True Bio, and have now occupied representative channels such as private medical examination giants and many benchmark hospitals.

3 clinical testing subsidiaries

The three clinical testing subsidiaries, namely Kuike, Dowell, and Premed, mainly rely on the Microdiag technology and products to create a unique third-party independent medical clinical testing center.

Microdiag inspection

Simplicity Sincerity Excellence

Adhering to the corporate culture of "simplicity, sincerity and excellence", "Microdiag" has always adhered to its original intention, and is committed to building "Microdiag" into a new type of international diagnostic product production and development based on technological innovation and independent research and development. service provider.

Culture